AFP and hepatocellular carcinoma: Both the training and validation groups showed that, compared with AFP ratio, BCLC stage, cirrhosis diagnosis, our nomogram provided a better clinical benefit and had significant clinical application in the prediction of HCC recurrence (Figures 5A–F).